Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.8)
Index Copernicus  – 171.00; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 9, September, p. 1083–1090

doi: 10.17219/acem/123350

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Monocyte chemoattractant protein-1, macrophage colony stimulating factor, survivin, and tissue inhibitor of matrix metalloproteinases-2 in analysis of damage and repair related to pediatric chronic kidney injury

Kinga Musiał1,A,B,C,D,F, Danuta Zwolińska1,C,E,F

1 Department and Clinic of Pediatric Nephrology, Wroclaw Medical University, Poland

Abstract

Background. Kidney injury in the course of chronic kidney disease (CKD) is a consequence of aggravated cell migration, inflammation, apoptosis, and fibrosis. However, the sequence of these phenomena, as well as of the reparatory mechanisms, are not fully known. Monocyte chemoattractant protein 1 (MCP-1) and macrophage colony-stimulating factor (MCSF) trigger monocyte migration to the sites of inflammation and their transition into macrophages. Tissue inhibitor of matrix metalloproteinases-2 (TIMP-2) plays a protective role against excessive matrix remodeling, whereas survivin is known for its anti-apoptotic activity.
Objectives. To analyze the serum, urine and fractional excretion (FE) values of MCP1, MCSF, TIMP-2, and survivin in children at subsequent stages of CKD being treated conservatively, and to analyze the potential applicability of these markers in the evaluation of CKD-related renal damage and protective mechanisms against it.
Material and Methods. The study group consisted of 70 children with conservatively treated CKD, stages 1–5, and 12 controls. The serum and urine concentrations of MCP1, MCSF, TIMP-2, and survivin were assessed using enzyme-linked immunosorbent assay (ELISA). The FE of these parameters in the urine was also assessed.
Results. The serum values of all parameters were significantly elevated at CKD stage 1 compared to the controls. The urinary concentrations of MCP-1 and MCSF (stages 1–2) rose earlier than TIMP-2 and survivin (stage 4) concentrations. The FE values started increasing at CKD stage 3 (MCP-1) or stage 4 (other parameters).
Conclusion. The complex analysis of serum/urinary/FE values of the selected parameters revealed a sequence of multifaceted CKD-related phenomena, when the migration of cells and inflammation were followed by delayed and insufficient anti-fibrotic and anti-apoptotic activity.

Key words

apoptosis, chronic kidney disease, fibrosis, inflammation, urinary fractional excretion

References (24)

  1. Guiteras R, Flaquer M, Cruzado JM. Macrophage in chronic kidney disease. Clin Kidney J. 2016;9(6):765–771.
  2. Laurent P, Jolivel V, Manicki P, et al. Immune-mediated repair: A matter of plasticity. Front Immunol. 2017;8:454. doi:10.3389/fimmu.2017.00454
  3. Takaori K, Nakamura J, Yamamoto S, et al. Severity and frequency of proximal tubule injury determines renal prognosis. J Am Soc Nephrol. 2016;27(8):2393–2406.
  4. Meng XM, Tang PMK, Li J, Lan HY. Macrophage phenotype in kidney injury and repair. Kidney Dis (Basel). 2015;1(2):138–146.
  5. Ma W, Tao L, Wang X, et al. Sorafenib inhibits renal fibrosis induced by unilateral ureteral obstruction via inhibition of macrophage infiltration. Cell Physiol Biochem. 2016;39(5):1837–1849.
  6. Lai KN, Leung JCK, Chan LYY, Guo H, Tang SCW. Interaction between proximal tubular cells and infiltrating monocytes/T cells in the proteinuric state. Kidney Int. 2007;71(6):526–538.
  7. Besbas N, Kalyoncu M, Cil O, Ozgul RK, Bakkaloglu A, Ozaltin F. MCP1 2518 A/G polymorphism affects progression of childhood focal segmental glomerulosclerosis. Ren Fail. 2015;37(9):1435–1439.
  8. Vianna HR, Soares CM, Silveira KD, et al. Cytokines in chronic kidney disease: Potential link of MCP-1 and dyslipidemia in glomerular diseases. Pediatr Nephrol. 2013;28(3):463–469.
  9. Musiał K, Bargenda A, Drożdż D, Zwolińska D. New markers of inflammation and tubular damage in children with chronic kidney disease. Dis Markers. 2017;2017:9389432.
  10. Kihara T, Miyata Y, Furukawa M, et al. Predictive value of serum macrophage colony-stimulating factor for development of aortic calcification in haemodialysis patients: A 6 year longitudinal study. Nephrol Dial Transplant. 2005;20(8):1647–1652.
  11. Haraguchi K, Kubo M, Saito T, et al. Serum level of macrophage colony-stimulating factor and atherosclerosis in hemodialysis patients. Nephron Clin Pract. 2006;102(1):c14–c20.
  12. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–921.
  13. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene. 2003;22(53):8581–8589.
  14. Chen J, Chen JK, Conway EM, Harris RC. Survivin mediates renal proximal tubule recovery from AKI. J Am Soc Nephrol. 2013;24(12):2023–2033.
  15. Jobst-Schwan T, Knaup KX, Nielsen R, et al. Renal uptake of the antiapoptotic protein survivin is mediated by megalin at the apical membrane of the proximal tubule. Am J Physiol Renal Physiol. 2013;305(5):F734–F744.
  16. Bargenda A, Musiał K, Zwolińska D. Urine survivin, E-cadherin and matrix metalloproteinases as novel biomarkers in children with chronic kidney disease. Biomarkers. 2015;20(3):177–182.
  17. Emlet DR, Pastor-Soler N, Marciszyn A, et al. Insulin-like growth factor binding protein 7 and tissue inhibitor of metalloproteinases-2: Differential expression and secretion in human kidney tubule cells. Am J Physiol Renal Physiol. 2017;312(2):F284–F296.
  18. Koyner JL, Shaw AD, Chawla LS, et al. Tissue inhibitor metalloproteinase-2 (TIMP-2) and IGF-binding protein-7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J Am Soc Nephrol. 2015;26(7):1747–1754.
  19. Bargenda A, Musiał K, Zwolińska D. Fractional excretion of survivin, EMMPRIN and MMP-7 in children with chronic kidney disease. Eur Med J. 2016;17:675–682.
  20. Musiał K, Zwolińska D. Fractional excretion as a new marker of tubular damage in children with chronic kidney disease. Clin Chim Acta. 2018;480:99–106.
  21. Lurbe E, Cifkova R, Kennedy Cruickshank J, et al; European Society of Hypertension. Management of high blood pressure in children and adolescents: Recommendations of the European Society of Hypertension. J Hypertens. 2009;27(9):1719–1742.
  22. Schwartz GJ, Muñoz A, Schneider MF, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol. 2009;20:629–637.
  23. Rice JC, Spence JS, Yetman DL, Safirstein RL. Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney. Ren Fail. 2002;24(6):703–723.
  24. Musiał K, Zwolińska D. Novel indicators of fibrosis-related complications in children with chronic kidney disease. Clin Chim Acta. 2014;430:15–19.
© Wroclaw Medical University